Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 19139565)

1.

Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function.

Urry Z, Xystrakis E, Richards DF, McDonald J, Sattar Z, Cousins DJ, Corrigan CJ, Hickman E, Brown Z, Hawrylowicz CM.

J Clin Invest. 2009 Feb;119(2):387-98. doi: 10.1172/JCI32354. Epub 2009 Jan 12.

2.

Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.

Merlo A, Calcaterra C, Mènard S, Balsari A.

J Leukoc Biol. 2007 Sep;82(3):509-18. Epub 2007 Jun 22.

3.

TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell.

Chiffoleau E, Heslan JM, Heslan M, Louvet C, Condamine T, Cuturi MC.

Int Immunol. 2007 Feb;19(2):193-201. Epub 2007 Jan 5.

4.

1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease.

Bartels LE, Jørgensen SP, Agnholt J, Kelsen J, Hvas CL, Dahlerup JF.

Int Immunopharmacol. 2007 Dec 15;7(13):1755-64. Epub 2007 Oct 5.

PMID:
17996686
5.

The Family of IL-10-secreting CD4+ T cells.

Fujio K, Okamura T, Yamamoto K.

Adv Immunol. 2010;105:99-130. doi: 10.1016/S0065-2776(10)05004-2. Review.

PMID:
20510731
6.

The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells.

Urry Z, Chambers ES, Xystrakis E, Dimeloe S, Richards DF, Gabryšová L, Christensen J, Gupta A, Saglani S, Bush A, O'Garra A, Brown Z, Hawrylowicz CM.

Eur J Immunol. 2012 Oct;42(10):2697-708. doi: 10.1002/eji.201242370. Epub 2012 Aug 20.

7.

TLR9 activation is defective in common variable immune deficiency.

Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A.

J Immunol. 2006 Feb 1;176(3):1978-87.

8.

A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.

Assaf A, Esteves H, Curnow SJ, Browning MJ.

Cell Immunol. 2009;259(1):90-9. doi: 10.1016/j.cellimm.2009.06.003. Epub 2009 Jun 6.

PMID:
19573862
9.
10.

Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse.

Vicari AP, Luu R, Zhang N, Patel S, Makinen SR, Hanson DC, Weeratna RD, Krieg AM.

Cancer Immunol Immunother. 2009 Apr;58(4):615-28. doi: 10.1007/s00262-008-0586-2. Epub 2008 Sep 19.

PMID:
18802696
11.

A novel regulatory B-cell population in sheep Peyer's patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses.

Booth JS, Griebel PJ, Babiuk LA, Mutwiri GK.

Mucosal Immunol. 2009 May;2(3):265-75. doi: 10.1038/mi.2009.6. Epub 2009 Mar 4.

PMID:
19262501
12.

Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation.

Qiao B, Li B, Yang X, Zhang H, Chu Y, Wang Y, Xiong S.

Cell Mol Immunol. 2005 Apr;2(2):130-5.

13.

Ncf1 provides a reactive oxygen species-independent negative feedback regulation of TLR9-induced IL-12p70 in murine dendritic cells.

Richter C, Juan MH, Will J, Brandes RP, Kalinke U, Akira S, Pfeilschifter JM, Hultqvist M, Holmdahl R, Radeke HH.

J Immunol. 2009 Apr 1;182(7):4183-91. doi: 10.4049/jimmunol.0800795.

14.

TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression.

Schroeder JT, Bieneman AP, Xiao H, Chichester KL, Vasagar K, Saini S, Liu MC.

J Immunol. 2005 Nov 1;175(9):5724-31.

15.

Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.

Yamamoto M, Kamigaki T, Yamashita K, Hori Y, Hasegawa H, Kuroda D, Moriyama H, Nagata M, Ku Y, Kuroda Y.

Oncol Rep. 2009 Aug;22(2):337-43.

PMID:
19578774
16.

Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.

Terzieva V, Popova D, Kicheva M, Todorova Y, Markova R, Martinova F, Elenkov I, Yankova M.

Int Immunopharmacol. 2009 Jul;9(7-8):831-6. doi: 10.1016/j.intimp.2009.03.009. Epub 2009 Mar 18.

PMID:
19303058
17.

Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression.

Dar A, Nichani AK, Benjamin P, Lai K, Soita H, Krieg AM, Potter A, Babiuk LA, Mutwiri GK.

Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):324-36. doi: 10.1016/j.vetimm.2008.02.007. Epub 2008 Feb 17.

PMID:
18367252
19.

Regulatory T cells and asthma.

Robinson DS.

Clin Exp Allergy. 2009 Sep;39(9):1314-23. doi: 10.1111/j.1365-2222.2009.03301.x. Epub 2009 Jun 17. Review.

PMID:
19538496
20.

Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils.

Månsson A, Cardell LO.

J Leukoc Biol. 2009 Apr;85(4):719-27. doi: 10.1189/jlb.0808494. Epub 2009 Jan 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk